Search
Search Results
-
Cost-of-Illness of Skin Cancer: A Systematic Review
BackgroundSkin cancer’s rising incidence demands understanding of its economic impact. The current understanding is fragmented because of the various...
-
A cost-benefit analysis of mass prostate cancer screening
BackgroundProstate cancer (PCa) causes a substantial health and financial burden worldwide, underscoring the need for efficient mass screening...
-
Determination of a cut-off COmprehensive Score for financial Toxicity (COST) for identifying cost-related treatment nonadherence and impaired health-related quality of life among Chinese patients with cancer
PurposeThis study aimed to determine a cut-off for the simplified Chinese version of the COmprehensive Score for financial Toxicity (COST) that could...
-
Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer
BackgroundTamoxifen (TAM) is recommended as the first-line strategy for men with estrogen receptor (ER)-positive early breast cancer who are...
-
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France
IntroductionEsophageal and gastroesophageal junction cancer (EC/GEJC) is a poor prognosis disease with a high risk of recurrence even in patients...
-
Estimating cost of prostate cancer management: an experience from Tanzania
BackgroundProstate cancer (PC) is a significant public health problem affecting men worldwide and ranks third in incidence and mortality in East...
-
The Cost-Effectiveness of Primary Prevention Interventions for Skin Cancer: An Updated Systematic Review
ObjectivePreventing the onset of skin malignancies is feasible by reducing exposure to ultraviolet radiation. We reviewed published economic...
-
Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study
BackgroundAnnual screening through low-dose computed tomography (LDCT) is recommended for heavy smokers. However, it is questionable whether all...
-
Cancer cost-related subjective financial distress among breast cancer: a sco** review
PurposeThis article provided a comprehensive sco** review, synthesizing existing literature on the financial distress faced by breast cancer...
-
Cost-Effectiveness Analysis of Digital Breast Tomosynthesis Added to Synthetic Mammography in Breast Cancer Screening in Brazil
BackgroundLiterature meta-analysis results show that digital breast tomosynthesis (DBT) combined with synthesized two-dimensional (s2D) mammograms...
-
Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature
Bladder cancer remains one of the costliest malignancies to manage. We provide a narrative review of literature assessing the economic burden and...
-
Cost-effectiveness of open pancreaticoduodenectomy with or without Heidelberg TRIANGLE operation for pancreatic cancer in China
ObjectivePancreatic cancer is a digestive malignancy with dismal prognosis. The advent of Heidelberg TRIANGLE dissection technique brings a turning...
-
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy
IntroductionOvarian cancer (OC) is the eighth most common cancer among women, and homologous recombination deficiency (HRD) is present in...
-
Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact
ObjectiveAnalyze the cost contributors and their impact on the drug cost avoidance (DCA) resulting from cancer clinical trials over the period of...
-
Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer
PurposeCardiovascular disease (CVD) is the leading cause of death after treatment for endometrial cancer (EC). There is clinical evidence that...
-
Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer
BackgroundColorectal cancer is a significant health concern worldwide, with metastatic CRC (mCRC) presenting a particularly challenging prognosis....
-
Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method
ObjectivesMonetizing health has sparked controversy and has implications for pricing strategies of emerging health technologies. Medical insurance...
-
Cost associated with diverting ostomy after rectal cancer surgery: a transnational analysis
BackgroundDiverting ileostomy and colostomy after total mesorectal excision reduces the risk of complications related to anastomotic leakages but is...
-
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany
BackgroundTriple-negative breast cancer (TNBC) is responsible for 10–20% cases of breast cancer and is resulting in rising healthcare costs. Thus,...
-
Cost-utility analysis of genomic profiling in early breast cancer in Colombia
BackgroundIn Colombia, the best strategy to establish indication for adjuvant chemotherapy in early breast cancer (EBC) remains unknown. This study...
